Author

L. Kazandijan

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1

Frequent Co-Authors

A. Carle· 1 shared C. Paulmann· 1 shared C. Reitinger· 1 shared E. Bluemle· 1 shared F. Nimmerjahn· 1 shared K. Beckmann· 1 shared N. Jurkschat· 1 shared S. Fischer· 1 shared

Activity by Year

2023-2023 · peak 1/yr

Co-Author Collaboration Network

9 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. Carle

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

ImmunologybioRxivPreprintJan 16, 2023

Fcgamma-receptor-independent controlled activation of CD40 canonical signaling by novel therpeutic antibodies for cancer therapy

C. Reitinger, K. Beckmann, A. Carle…·S. Fischer

Novel Fc-silenced anti-CD40 antibodies activate antigen-presenting cells and humanized mice without Fcγ-receptor dependence, showing efficacy and reduced toxicity compared to existing therapies.

DOI 10.1101/2023.01.16.521736

humanexperimental assay

𝕏 PostBluesky